Skip to main content
SpringerLink
Log in

Penicillin tolerance and treatment failure in group A streptococcal pharyngotonsillitis

  • Review
  • Published:
European Journal of Clinical Microbiology and Infectious Diseases Aims and scope Submit manuscript

Abstract

Failure of treatment of group A streptococcal pharyngitis and tonsillitis is well documented. One of the possible explanations for treatment failure is penicillin tolerance in group A streptococci. Reports on the prevalence of penicillin tolerance among group A streptococci (0–100%) and the presumed relationship with therapeutic failure vary considerably. Therefore, it appears worthwhile to review pharyngotonsillitis studies, devoting special attention to the variables of MIC-MBC laboratory determinations such as inoculum preparation, composition and volume of test medium, and the criteria used to define penicillin tolerance. Alternative methods (gradient-replica plate method, β-lactamase disk test, time-kill assay, and cell-lysis assay) are discussed. It is concluded that technical factors and the definitions used influenced the reported rates of penicillin tolerance. The epidemiological data suggest that tolerance is not limited to a single streptococcal serotype. Furthermore, there is not sufficient data to support a correlation between in vitro penicillin tolerance of group A streptococci and treatment failure, either in clinical cases or in animal studies. On the other hand, evidence to exclude penicillin tolerance as a cause of treatment failure is also not available. Therefore, at present, penicillin tolerance cannot be ruled out as a cause of penicillin treatment failures.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Vukmir RB: Adult and pediatric pharyngitis: a review. Journal of Emergency Medicine 1992, 10: 607–616.

    Google Scholar 

  2. Peter G: Streptococcal pharyngitis: current therapy and criteria for evaluation of new agents. Clinical Infectious Diseases 1992, 14, Supplement 2: 218–223.

    Google Scholar 

  3. Moellering RC: Revolutionary changes in the macrolide and azalide antibiotics. American Journal of Medicine 1991, 91, Supplement 3A: 1–4.

    Google Scholar 

  4. Hooton TM: A comparison of azithromycin and penicillin V for the treatment of streptococcal pharyngitis. American Journal of Medicine 1991, 91, Supplement 3A: 23–26.

    Google Scholar 

  5. Schrock CG: Clarithromycih vs. penicillin in the treatment of streptococcal pharyngitis. Journal of Family Practice 1992, 35:622–626.

    Google Scholar 

  6. Smith TD, Huskins WC, Kim KS, Kaplan EL: Efficacy of β-lactamase-resistant penicillin and influence of penicillin tolerance in eradicating streptococci from the pharynx after failure of penicillin therapy for group A streptococcal pharyngitis. Journal of Pediatrics 1987, 110: 777–782.

    Google Scholar 

  7. Kaufhold A, Podbielski A, Kühnemund O, Lütticken R: Infektionen durchStreptococcus pyogenes: neuere Aspekte zur Diagnostik, Epidemiologie, Klinik und Therapie. Immunität und Infektion 1992, 20: 192–199.

    Google Scholar 

  8. Kaplan EL, Johnson DR, Cleary PP: Group A streptococcal serotypes isolated from patients and sibling contacts during the resurgence of rheumatic fever in the United States in the mid-1980s. Journal of Infectious Diseases 1989, 159: 101–103.

    Google Scholar 

  9. Bisno AL: Group A streptococcal infections and acute rheumatic fever. New England Journal of Medicine 1991, 325: 783–793.

    Google Scholar 

  10. Stjernquist-Desatnik A, Orrling A, Schalén C, Kamme C: Penicillin tolerance in group A streptococci and treatment failure in streptococcal tonsillitis. Acta Oto-Laryngologica 1992, Supplement 492: 68–71.

    Google Scholar 

  11. Kim KS, Kaplan EL: Association of penicillin tolerance with failure to eradicate group A streptococci from patients with pharyngitis. Journal of Pediatrics 1985, 107: 681–684.

    Google Scholar 

  12. Roos K, Holm SE, Ekedahl C: Treatment failure in acute streptococcal tonsillitis in children over the age of 10 and in adults. Scandinavian Journal of Infectious Diseases 1985, 17:357–365.

    Google Scholar 

  13. Dagan R, Ferne M, Scheinis M, Alkan M, Katzenelson E: An epidemic of penicillin-tolerant group A streptococcal pharyngitis in children living in a closed community: mass treatment with erythromycin. Journal of Infectious Diseases 1987, 156: 514–516.

    Google Scholar 

  14. Gastanaduy AS, Kaplan EL, Huwe BB, McKay C, Wannamaker LW: Failure of penicillin to eradicate group A streptococci during an outbreak of pharyngitis. Lancet 1980, ii: 498–502.

    Google Scholar 

  15. Milatovic D, Knauer J: Cefadroxil versus penicillin in the treatment of streptococcal tonsillopharyngitis. European Journal of Clinical Microbiology & Infectious Diseases 1989, 8:282–288.

    Google Scholar 

  16. Feldman S, Bisno AL, Lott L, Dodge R, Jackson RE: Efficacy of benzathine penicillin G in group A streptococcal pharyngitis: reevaluation. Journal of Pediatrics 1987, 110:783–787.

    Google Scholar 

  17. Milatovic D, Adam D, Hamilton H, Matermen E: Cefprozil versus penicillin V in treatment of streptococcal tonsillopharyngitis. Antimicrobial Agents and Chemotherapy 1993, 37: 1620–1623.

    Google Scholar 

  18. Brook I: Penicillin V and rifampicin for streptococcal pharyngitis. Journal of Pediatrics 1985, 107: 825–826.

    Google Scholar 

  19. Roos K, Grahn E, Holm SA: Evaluation of beta-lactamase activity and microbial interference in treatment failures of acute streptococcal tonsillitis. Scandinavian Journal of Infectious Diseases 1986, 18: 313–319.

    Google Scholar 

  20. Brook I: The role of β-lactamase-producing bacteria in the persistence of streptococcal tonsillar infection. Reviews of Infectious Diseases 1984, 6: 601–607.

    Google Scholar 

  21. Roos K, Holm SA, Grahn E, Lind L: Alpha-streptococci as supplementary treatment of recurrent streptococcal tonsillitis: a randomized placebo controlled study. Scandinavian Journal of Infectious Diseases 1993, 25: 31–35.

    Google Scholar 

  22. Wilkinson BJ: A new type of penicillin resistance ofStaphylococcus aureus. Lancet 1977, i: 443–447.

    Google Scholar 

  23. Taylor PC, Schoenknecht FD, Sherris JC, Linner EC: Determination of minimal bactericidal concentrations of oxacillin forStaphylococcus aureus: influence and significance of technical factors. Antimicrobial Agents and Chemotherapy 1983, 23: 142–150.

    Google Scholar 

  24. Stratton CW: The role of the microbiology laboratory in the treatment of infective endocarditis. Journal of Antimicrobial Chemotherapy 1987, 20, Supplement A: 41–49.

    Google Scholar 

  25. Washington JA II, Sutter VL: Dilution susceptibility test: agar and macro-broth dilution procedures. In: Lenette EH, Balows A, Hausier WJ Jr, Truant JP (ed): Manual of clinical microbiology. American Society for Microbiology, Washington, DC, 1980, p. 453–458.

    Google Scholar 

  26. Sherris JC: Problems in in vitro determination of antibiotic tolerance in clinical isolates. Antimicrobial Agents and Chemotherapy 1986, 30: 633–637.

    Google Scholar 

  27. Stratton CW, Cooksey RC: Susceptibility test: special tests. In: Balows A, Hausier WJ Jr, Herrmann KL, Isenberg HD, Shadomy HJ (ed): Manual of clinical microbiology. American Society for Microbiology, Washington, DC, 1991, p. 1153–1165.

    Google Scholar 

  28. Handwerger S, Tomasz A: Antibiotic tolerance among clinical isolates of bacteria. Reviews of Infectious Diseases 1985, 7: 368–386.

    Google Scholar 

  29. Van Asselt GJ, Mouton RP: Detection of penicillin tolerance inStreptococcus pyogenes. Journal of Medical Microbiology 1993, 38: 197–202.

    Google Scholar 

  30. Michel MF, Van Leeuwen WB: Degree and stability to penicillin inStreptococcus pyogenes. European Journal of Clinical Microbiology & Infectious Diseases 1989, 8: 225–232.

    Google Scholar 

  31. Dagan R, Ferne M: Association of penicillin-tolerant streptococci with epidemics of streptococcal pharyngitis in closed communities. European Journal of Clinical Microbiology & Infectious Diseases 1989, 8: 629–631.

    Google Scholar 

  32. Goessens WHF, Fontijne P, Van Raffe M, Michel MF: Tolerance percentage as a criterion for the detection of tolerantStaphylococcus aureus strains. Antimicrobial Agents and Chemotherapy 1984, 25: 575–578.

    Google Scholar 

  33. Wittler RR, Yamada SM, Bass JW, Hamill R, Wiebe RA, Ascher DP: Penicillin tolerance and erythromycin resistance of group A β-hemolytic streptococci in Hawaii and the Philippines. American Journal of Diseases of Children 1990, 144: 587–589.

    Google Scholar 

  34. Van Asselt GJ, Mouton RP: Low prevalence of penicillin tolerance in group A streptococci. Journal of Antimicrobial Chemotherapy 1995, 35: 555–557.

    Google Scholar 

  35. Chaudhary S, Bilinski SA, Hennessy JL, Soler SM, Wallace SE, Schacht LM, Bisno AI: Penicillin V and rifampin for the treatment of group A streptococcal pharyngitis: a randomized trial of 10 days penicillin vs. 10 days penicillin with rifampin during the final four days of therapy. Journal of Pediatrics 1985, 106: 481–486 and 107: 825–826 (letter).

    Google Scholar 

  36. Betriu C, Campos E, Cabronero C, Fernandez A, Picazo JJ, Noriega AR: Penicillin tolerance in group A streptococci. European Journal of Clinical Microbiology & Infectious Diseases 1989, 8: 799–800.

    Google Scholar 

  37. Allen JL, Sprunt K: Discrepancy between minimum inhibitory and minimum bactericidal concentrations of penicillin for group A and group B β-hemoiytic streptococci. Journal of Pediatrics 1978, 93: 69–71.

    Google Scholar 

  38. Krasinski K, Hanna B, LaRussa P, Desiderio D: Penicillin tolerant group A streptococci. Diagnostic Microbiology and Infectious Disease 1986, 4: 291–297.

    Google Scholar 

  39. Brett MSY: Antibiotic susceptibilities and penicillin tolerance of group A streptococci isolated in New Zealand in 1990. Journal of Antimicrobial Chemotherapy 1994, 33: 668–689.

    Google Scholar 

  40. Tuomanen E, Durack DT, Tomasz A: Antibiotic tolerance among clinical isolates of bacteria. Antimicrobial Agents and Chemotherapy 1986, 30: 521–526.

    Google Scholar 

  41. Woolfrey BF, Lally RT, Gresser-Burns M: Penicillin tolerance in group A streptococci. Journal of Infectious Diseases 1988, 158: 487–488.

    Google Scholar 

  42. James PA: Comparison of four methods for the determination of MIC and MBC of penicillin for viridans streptococci and the implications for penicillin tolerance. Journal of Antimicrobial Chemotherapy 1990, 25: 209–216.

    Google Scholar 

  43. Woolfrey BF, Lally RT, Ederer MN: Influence of technical factor variations during inoculum preparation on the agar dilution plate-count method for quantitation ofStaphylococcus aureus oxacillin persisters. Antimicrobial Agents and Chemotherapy 1986, 30: 792–793.

    Google Scholar 

  44. Murray PR, Jorgensen JH: Quantitative susceptibility test methods in major United States medical centers. Antimicrobial Agents and Chemotherapy 1981, 20: 66–70.

    Google Scholar 

  45. Mayhall CG, Apollo E: Effect of storage and changes in bacterial growth phase and antibiotic concentrations on antimicrobial tolerance inStaphylococcus aureus. Antimicrobial Agents and Chemotherapy 1980, 18: 784–788.

    Google Scholar 

  46. Strömberg A, Schwan A, Cars O: Bacteriological and serological aspects of group A streptococcal pharyngotonsillitis caused by group A streptococci. European Journal of Clinical Microbiology & Infectious Diseases 1988, 7:172–174.

    Google Scholar 

  47. Grahn E, Holm SE, Roos K: Penicillin tolerance in betastreptococci isolated from patients with tonsillitis. Scandinavian Journal of Infectious Diseases 1987, 19: 421–426.

    Google Scholar 

  48. Dagan R, Ferne M: Reply. Journal of Infectious Diseases 1988, 158: 488.

    Google Scholar 

  49. Sahm DF, Washington JA II: Antibacterial susceptibility test: dilution methods. In: Balows A, Hausler WJ Jr, Herrmann KL, Isenberg HD, Shadomy HJ (ed): Manual of clinical microbiology. American Society for Microbiology, Washington, DC, 1991, p. 1105–1116.

    Google Scholar 

  50. National Committee for Clinical Laboratory Standards. Methods for determining bactericidal activity of antimicrobial agents. Proposed guidelines M26-P. NCCLS, Villanova, PA, 1987.

    Google Scholar 

  51. Brook I: Inoculum effect. Reviews of Infectious Diseases 1989, 11: 361–368.

    Google Scholar 

  52. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A2. NCCLS, Villanova, PA, 1990.

    Google Scholar 

  53. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. Fourth informational supplement M100-S4. NCCLS, Villanova, PA, 1992.

    Google Scholar 

  54. Masuda G, Tomioka S, Uchida H, Hasegawa M: Bacteriostatic and bactericidal activities of selected beta-lac tam antibiotics studied on agar plates. Antimicrobial Agents and Chemotherapy 1977, 11: 376–382.

    Google Scholar 

  55. Sabath LD, Mokhbat JE: What is the clinical significance of tolerance to β-lactam antibiotics? In: Remington JS, Schwarz MN (ed): Current clinical topics in infectious diseases. McGraw-Hill, New York, 1983, p. 358–377.

    Google Scholar 

  56. Kim KS, Anthony BF: Use of penicillin-gradient and replicate plates for the demonstration of tolerance to penicillin in streptococci. Journal of Infectious Diseases 1983, 148:488–491.

    Google Scholar 

  57. Dankert J, Holloway Y, Joldersma W, Hess J: Screening for penicillin tolerance in viridans streptococci by a simple disk method. Journal of Clinical Microbiology 1982, 16: 744–746.

    Google Scholar 

  58. Slater GJ, Greenwood D: Detection of penicillin tolerance in streptococci. Journal of Clinical Pathology 1983, 36: 1353–1356.

    Google Scholar 

  59. Petitti DB: Meta-analysis, decision analysis, and cost-effectiveness analysis. Methods for quantitative synthesis in medicine. Oxford University Press, Oxford, UK, 1994.

    Google Scholar 

  60. Voorn GP, Thompson J, Goessens WHF, Schmal-Bauer WC, Broeders PHM: Role of tolerance in cloxacillin treatment of experimentalStaphylococcus aureus endocarditis. Journal of Infectious Diseases 1991, 163: 640–643.

    Google Scholar 

  61. Brennan RO, Durack DT: Therapeutic significance of penicillin tolerance in experimental streptococcal endocarditis. Antimicrobial Agents and Chemotherapy 1983, 23: 273–277.

    Google Scholar 

  62. Goessens WHF, Fontijne P, Michel MF: Responses of tolerant and nontolerantStaphylococcus aureus strains to methicillin treatment in an experimental infection in mice. Antimicrobial Agents and Chemotherapy 1984, 26: 829–832.

    Google Scholar 

  63. Hess J, Dankert J, Durack D: Significance of penicillin tolerance in vivo: prevention of experimentalStreptococcus sanguis endocarditis. Journal of Antimicrobial Chemotherapy 1983, 11: 555–564.

    Google Scholar 

  64. Meeson J, McColm AA, Acred P, Greenwood D: Differential response to benzylpenicillin in vivo of tolerant and non-tolerant variants ofStreptococcus sanguis II. Journal of Antimicrobial Chemotherapy 1990, 25: 103–109.

    Google Scholar 

  65. Hoogeterp JJ, Mattie H, Krul AM, Terporteren P, Van Furth R: Comparison of in vivo and in vitro activities of antibiotics with different modes of action against a tolerant and non-tolerantStaphylococcus aureus strain. Scandinavian Journal of Infectious Diseases 1989, 21: 95–101.

    Google Scholar 

  66. Voorn GP, Kuyvenhoven J, Goessens WHF, Schmal-Bauer WC, Breeders PHM, Thompson J, Michel MF: Role of tolerance in treatment and prophylaxis of experimentalStaphylococcus aureus endocarditis with vancomycin, teicoplanin, and daptomycin. Antimicrobial Agents and Chemotherapy 1994, 38: 487–493.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medical Microbiology, Leiden University Hospital, PO Box 9600, 2300, RC Leiden, The Netherlands

    G. J. van Asselt, R. P. Mouton & C. P. A. van Boven

  2. Department of Medical Microbiology, Westeinde Hospital, Lijnbaan 32, 2512, VA Den Haag, The Netherlands

    G. J. van Asselt

Authors
  1. G. J. van Asselt
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R. P. Mouton
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C. P. A. van Boven
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

van Asselt, G.J., Mouton, R.P. & van Boven, C.P.A. Penicillin tolerance and treatment failure in group A streptococcal pharyngotonsillitis. Eur. J. Clin. Microbiol. Infect. Dis. 15, 107–115 (1996). https://doi.org/10.1007/BF01591482

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01591482

Keywords

Search

Navigation